Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Gives $860,000 to New Swiss Biosystems Center

NEW YORK, Nov. 17 (GenomeWeb News) - Novartis has contributed 1 million Swiss francs ($859,000) to the new Center for Biosystems Science in Engineering of ETH Zurich, the institute announced this week.


The Basel-based center is part of Project SystemsX, a national network for systems biology that is supported by ETH Zurich and the Universities of Zurich and Basel. The center will focus on interdisciplinary research in biology, physics, mathematics, computational science, chemistry, information technology, biotechnology, and nanotechnology.


The contribution from Novartis is intended to fund scientists who will be appointed to the center. Positions for the first four professors will be announced in the next few weeks in the journals Science and Nature and include two specialists in experimental systems biology and one "internationally known expert" each in the areas of computational biology and systems nanobiology.


The center is expected to open in the autumn 2005.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.